Tumor cell invasion and angiogenesis in the central nervous system

Current Opinion in Oncology

Volumn 9, Issue 3, 1997, Pages 223-229

  Bjerkvig, Rolf ^a   Lund Johansen, Morten ^b   Edvardsen, Klaus ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GROWTH FACTOR; PROTEINASE;

ANGIOGENESIS; ANIMAL MODEL; BRAIN TISSUE; CANCER INVASION; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM METASTASIS; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GLIOMA; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; TUMOR SPHEROID; TUMOR VASCULARIZATION;

EID: 0030857842     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199709030-00002     Document Type: Review

References (68)

1. Kleihues P, Soylemezoglu F, Schauble B, Scheithauer BW, Burger PC: Histopathology, classification, and grading of gliomas. Glia 1995, 15:211-221. The authors review the classification of glial tumors and important genotypic and phenotypic characteristics that occur during glioma progression.
2. Scherer HJ: Structural development in gliomas. Am J Cancer 1938, 34:333-351.
3. Gilles FH, Sobel EL, Tavare CJ, Leviton A, Hedley Whyte ET: Age-related changes in diagnoses, histological features, and survival in children with brain tumors: 1930-1979: the Childhood Brain Tumor Consortium. Neurosurgery 1995, 37:1056-1068.
4. Scherer HJ: Cerebral astrocytomas and their derivatives. Am J Cancer 1940, 40:159-198.
5. Burger PC, Heinz ER, Shibita T, Kleihues P: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 1988, 68:698-704.
6. McComb RD, Burger PC: Pathologic analysis of primary brain tumors. Neurol Clin 1985, 3:711-728.
7. Mareel MM, Bracke M, Van-Roy F: Cancer metastasis: negative regulation by an invasion suppressor complex. Cancer Detect Prev 1995, 19:451-464. Metastatic cells express either an invasive (I+) , or noninvasive (I-) phenotype, regardless of their oncogene or tumor suppressor gene status. The cell-cell adhesion complex E-cadherin/catenins/actin, when downregulated, may turn cells from the I- to the I+ phenotype.
8. Druckrey H, Preussmann R, Ivankovic S, Schmähl D: Organotrope carcinogen wirkungen bei 65 verschiedenen N-nitrosoverbindungen an BD-ratten. Z Krebsforsch 1967, 69:103-201.
9. Jänisch W, Schreiber D: Experimental Tumors of the Central Nervous System, ed 1 (English). Edited by Bigner DD, Swenberg JA, Kalamazoo: Upphn; 1977.
10. Benda P, Someda K, Messer J, Sweet WH: Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture. J Neurosurg 1971, 34:310-323.
11. Laerum OD, Rajewsky MF, Schachner M, Stavrou D, Haglid KG, Haugen A: Phenotypic properties of neoplastic cell lines developed from fetal rat brain cells in culture after exposure to ethylnitrosourea in vivo. K Krebsforsch 1977, 89:273-295.
12. Kooistra KL, Rodriguez M, Powis G, Yaksh TL, Harty GJ, Hilton JF, Laws ER: Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat. Cancer Res 1986, 46:317-323.
13. Erkell LJ, Schirrmacher V: Quantitative in vitro assay for tumor cell invasion through extracellular matrix or into protein gels. Cancer Res 1988, 48:6933-6937.
14. de Ridder L, Laerum OD, Mork SJ, Bigner DD: Invasiveness of human glioma cell lines in vitro: relation to tumorigenicity in athymic mice. Acta Neuropathol (Berl) 1987, 72:207-213.
15. Bjerkvig R, Laerum OD, Mella O: Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo. Cancer Res 1986, 46:4071-4079.
16. Bjerkvig R, Steinsvȧg SK, Laerum OD: Reaggregation of fetal rat brain cell in a stationary culture system I: methodology and cell identification. In Vitro Cell Dev Biol 1986, 22:180-192.
17. Bjerkvig R: Reaggregation of fetal rat brain cells in a stationary culture system II: an ultrastructural characterization. In Vitro Cell Dev Biol 1986, 22:193-200.
18. Engebraaten O, Bjerkvig R, Lund-Johansen M, Wester K, Mørk S, Backlund EO, Laerum OD: Interaction between human brain tumorbiopsies and fetal rat brain tissue studied in vitro. Acta Neuropathol 1990, 81:130-140.
19. Pedersen PH, Edvardsen K, Garcia-Cabrera I, Mahesparan R, Thorsen J, Mathisen B, Rosenblum M, Bjerkvig R: Migratory patterns of lacZ transfected human glioma cells in the rat brain. Int J Cancer 1995 62:767-771. The in vitro brain tumor versus brain aggregate invasion system is presented.
20. Nygaard SJ, Pedersen PH, Mikkelsen T, Terzis AJ, Tysnes OB, Bjerkvig R: Glioma cell invasions visualized by scanning confocal laser microscopy in an in vitro co-culture system. Invasion Metastasis 1995, 15:179-188. The in vitro brain tumor versus brain aggregate invasion system is presented.
21. Bernstein JJ, Goldberg WJ, et al.: Human malignant astrocytoma xenografts migrate in rat brain: a model for central nervous system cancer research. J Neurosci: Res 1989, 22:134-143.
22. Pedersen PH, Marienhagen K, Mork SJ, Bjerkvig R: Migratory pattern of fetal rat brain cells and human glioma cells in the adult rat brain. Cancer Res 1993, 53:5158-5165.
23. Emmett CJ, Lawrence JM, Raisman G, Seeley PJ: Cultured epithelioid astrocytes migrate after transplantation into the adult brain. Brain Res 1991, 565:1-7.
24. Hou YJ, Yu AC, Garcia JM, Aotaki-Keen A, Lee YL, Eng LF, Hjelmeland LJ, Menon VK: Astrogliosis in culture: IV. effects of basic fibroblast growth factor. J Neurosci Res 1995, 40:359-370.
25. Liesi P, Kakkola S, Dahl D, Vaheri A: Laminin is induced in astrocytes of adult brain by injury. EMBO J 1984, 3:683-686.
26. Liotta LA, Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991, 51:5054-5059.
27. Rutka JT, Apodaca G, Stern R, Rosenblum M: The extracellular matrix of the central and peripheral nervous systems: structure and function. J Neurosurg 1988, 69:155-170
28. Giese A, Rief MD, Loo MA, Berens ME: Determinants of human astrocytoma migration. Cancer Res 1994, 54:3897-3904. The authors describe a heterogeneous distribution of integrins as well as biologic reponses (migration and adhesion) to extracellular matrix proteins in eight glioma cell lines.
29. Bjerkvig R, Laerum OD, Rucklidge GJ: Immunocytochemical characterization of extracellular matrix proteins expressed by cultured glioma cells. Cancer Res 1989, 49:5424-5428.
30. Liesi P: Extracellular matrix and neuronal movement. Experientia 1990, 46:900-907.
31. Liesi P: Laminin-immunoreactive glia distinguish regenerative adult CNS systems from non-regenerative ones. EMBO J 1985, 4:2505-2511.
32. Zhang ET, Inman CB, Weller RO: Interrelationships of the pia mater and the perivascular (Virchow-Robin) spaces in the human cerebrum. J Anat 1990, 170:111-123.
33. Hynes RO: Integrins: versatility, modulation, and signalling in cell adhesion. Cell 1992, 69:11-25. This is an excellent article reviewing the structure and function of integrins. The nomenclature of the α and γ subunits and their corresponding ligand binding sites are described. The article focuses also on integrin-mediated signalling over the cell membrane.
34. Paulus W, Tonn JC: Basement membrane invasion of glioma cells mediated by integrin receptors. J Neurosurg 1994, 80:515-519. Using the Matrigel invasion assay, the authors investigate cells from glioma biopsies and cell lines. Treatment with antibodies against specific integrins may lead to an inhibition or stimulation of invasion, suggesting a concerted and complex action between different integrins during invasion.
35. Paulus W, Baur I, Schuppan D, Roggendorf W: Characterization of integrin receptors in normal and neoplastic human brain. Am J Pathol 1993, 143:154-163.
36. Tysnes BB, Larsen LF, Ness GO, Mahesparan R, Edvardsen K, Garcia-Cabrera I, Bjerkvig R: Stimulation of glioma-cell migration by laminin and inhibition by anti-α3 and anti-β1 integrin antibodies. Int J Cancer 1996, 67:777-784.
37. Picker LJ, Nakache M, Butcher EC: Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 1989, 109:927-937.
38. Kaaijk P, Troost D, Morsink F, Keehnen RM, Leenstra S, Bosch DA, Pals ST: Expression of CD44 splice variants in human primary brain tumors. J Neurooncol 1995, 26:185-190.
39. Eibl RH, Pietsch T, Moll J, Skroch Angel P, Heider KH, von-Ammon K, Wiestler OD, Ponta H, Kleihues P, Herrlich P: Expression of variant CD44 epitopes in human astrocytic brain tumors. J Neurooncol 1995, 26:165-170.
40. Li H, Hamou MF, deTribolet N, Jaufeerally R, Hofmann M, Diserens AC, Van-Meir EG: Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. Cancer Res 1993, 53:5345-5349.
41. Merzak A, Koocheckpour S, Pilkington GJ: CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 1994, 54:3988-3992.
42. Koochekpour S, Merzak A, Pilkington GJ: Extracellular matrix proteins inhibit proliferation, upregulate migration and induce morphological changes in human glioma cell lines. Eur J Cancer 1995, 31:375-380.
43. Koochekpour S, Pilkington GJ, Merzak A: Hyaluronic acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro. Int J Cancer 1995, 63:450-454.
44. Birkedal-Hansen H: Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995, 7:728-735. This article reviews the interactive process between metalloproteinases, inhibitors, growth factors, and the extracellular matrix, with a particular focus on recent discoveries regarding metalloproteinase precursor activation mechanisms.
45. Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 1995, 83:298-307. The study demonstrates a concerted overexpression of matrix metalloproteinases and inhibitors in glioma biopsies and cell lines. Furthermore, it is shown that glioma cell invasion into Matrigel is reduced by tissue inhibitor of metalloproteinases (TIMP) treatment.
46. Lund-Johansen M, Rucklidge GJ, Milne G, Bjerkvig R: A metalloproteinase, capable of destroying cultured brain tissue isolated from rat glioma cells. Anticancer Res 1991, 11:1001-1006.
47. Abe T, Mon T, Kohno K, Seiki M, Hayakawa T, Welgus HG, Hori S, Kuwano M: Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Clin Exp Metastasis 1994, 12:296-304.
48. Bindal AK, Hammoud M, Shi WM, Wu SZ, Sawaya R, Rao JS: Prognostic significance of proteolytic enzymes in human brain tumors. J Neurooncol 1994, 22:101-110.
49. Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D, Rao JS: Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res 1993, 53:4143-4147.
50. Mikkelsen T, Yan PS, Ho KL, Sameni M, Sloane BF, Rosenblum ML: Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. J Neurosurg 1995, 83:285-290.
51. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364. This article reviews the mechanisms controlling tumor angiogenesis and the crucial role of blood vessel formation during malignant progression
52. Zagzag D: Angiogenic growth factors in neural embryogenesis and neoplasia. Am J Pathol 1995, 146:293-309.
53. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845. This article demonstrated that hypoxic tumor cells overexpress VEGF. which in turn stimulates the formation of new vessels.
54. Tsai JC, Goldman CK, Gillespie GY: Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg 1995, 82:864-873.
55. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994, 367:576-579. Inhibition of VEGF-receptor function in a transplantable VEGF-r dominant-negative glioblastoma lead to impaired tumor growth and cell death.
56. Goldman CK, Kim J, Wong WL, King V, Brock T, Gillespie GY: Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiform pathophysiology. Mol Biol Cell 1993, 4:121-133.
57. Brouty Boye D, Zetter BR: Inhibition of cell motility by Interferon. Science 1980, 208:516-518.
58. Sato Y, Abe M, Takaki R: Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells. Biochem Biophys Res Commun 1990, 172:595-600.
59. Plate KH, Risau W: Angiogenesis in malignant gliomas. Glia 1995, 15:339-347. The authors review their previous work and describe how a paracrine regulation of angiogenesis is found in developing brain and gliomas but not in the adult brain.
60. Bloom WH, Carstairs KC, Crompton MR: Autologous glioma transplantation. Lancet 1960, 1:77-78.
61. Pedersen PH, Rucklidge GJ, Mork SJ, Terzis AJ, Engebraaten O, Lund-Johansen M, Backlund EO, Laerum OD, Bjerkvig R: Leptomeningeal tissue: a barrier against brain tumor cell invasion. J Natl Cancer Inst 1994, 86:1593-1599. The authors demonstrate that rat brain cell aggregates permit invasion of glioma cells but not from brain metastasis biopsies, whereas aggregates of leptomeningeal cells are resistant towards glioma cell invasion but get invaded when cocultured with metastatic cells.
62. Weller RO, Koda S, Zhang ET: Pathways of fluid drainage from the brain: morphological aspects and immunological significance in rat and man. Brain Pathol 1992, 2:277-289.
63. Hutchings M, Weller RO: Anatomical relationships of the pia mater to cerebral blood vessels in man. J Neurosurg 1986, 65:316-325.
64. Onda K, Tanaka R, Takahashi H, Takeda N, Ikuta F: Cerebral glioblastoma with cerebrospinal fluid dissemination: a clinicopathological study of 14 cases examined by complete autopsy. Neurosurgery 1989, 25:533-540.
65. Ueba T, Takahashi JA, Fukumoto M, Ohta M, ItO N, Oda Y, Kikuchi H, Hatanaka M: Expression of fibroblast growth factor receptor-1 in human glioma and meningioma tissues. Neurosurg 1994, 34:221-225.
66. Todo T, Adams EF, Fahlbusch R, Dingermann T, Werner H: Autocrine growth stimulation of human meningioma cells by platelet-derived growth factor. J Neurosurg 1996, 84:852-858.
67. Sanfilippo JS, Rao CV, Guarnaschelli JJ, Woost PG, Byrd VM, Jones E, Schultz GS: Detection of epidermal growth factor and transforming growth factor alpha protein in meningiomas and other tumors of the central nervous system in human beings. Surg Gynecol Obstet 1993, 177:488-496.
68. Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD, Laerum OD: Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res 1990, 50:6039-6044.